HH-009

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameHH-009
Drug Alias NameHH-009HH009
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionFibroblast growth factor 19 inhibitors
TargetsFibroblast growth factor 19
Therapy Area/IndicationsSolid tumoursCarcinoma, HepatocellularNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHuahui Health Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHuahui Health Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Hepatocellular
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A